About I believe that disease is predictable and that the leading cause of death is ignorance and inaction.My mission is to change the status quo, go beyond the diagnosis of disease, and advance precision preventative medicine into mainstream medical practice.Over the past 30 years, I have invented and developed advanced diagnostic and bioinformatic technologies, designed and manufactured novel and natural biochemical precursors, and identified a treasure trove of biochemical markers that predict numerous diseases including Alzheimer’s and dementia, Parkinson’s, multiple sclerosis, stroke, autism, ALS, multiple system atrophy, various mental illnesses, and cancers. The study of Plasmalogens is vital in predicting several diseases. Plasmalogens are critical membrane components that help cells communicate with each other and function harmoniously. I have studied Plasmalogens since 2006, and research has expanded to show that Plasmalogens are the root cause of neurodegeneration that leads to Alzheimer’s, Parkinson’s, and MS. My passion is to educate the world about the life-extending benefits possible when Plasmalogen health is harnessed. I have released over 50 scientific publications, with research on over 25 diseases and have over 30 Academic Collaborations worldwide. I have extensively patented my inventions including patents for Plasmalogen Compounds, Pharmaceutical Compositions, and treatment methods for age related diseases that are mediated by Plasmalogen Deficiencies.My focus, As the founder and CEO of Prodrome Sciences Inc., is to build a next-generation team of dedicated researchers and medical professionals who are determined to maximize longevity for millions of people around the world. Currently, I have over 10 clinical trials ongoing with over 8,000 people globally. These trials are focused on various aspects of aging and diseases such as various cancers, Alzheimer’s disease and dementia, Parkinson’s disease, schizophrenia, bipolar disorder, and depression.I have extensive experience compiling and training teams of professionals. I have built ISO certified, FDA compliant manufacturing facilities, CAP/CLIA certified laboratories, and advanced programs for researching the biochemical mechanisms and causes of human health disorders and developing diagnostic and treatment solutions for them. Plasmalogens are a type of phospholipid found in cell membranes, particularly in the brain, heart, and liver. They are unique in that they contain a vinyl ether bond in the sn-1 position of the glycerol backbone, whereas most phospholipids contain a ester bond in this position. Plasmalogens play important roles in cellular function, including maintaining membrane fluidity and stability, acting as precursors for signaling molecules, and serving as a source of energy for cells. They also have antioxidant properties, helping to protect cells against oxidative stress. Studies have shown that a decrease in plasmalogen levels is associated with several diseases, including Alzheimer's disease, cardiovascular disease, and nonalcoholic fatty liver disease. Researchers are exploring the potential of plasmalogen supplementation as a therapeutic strategy for these and other conditions. Despite their importance, the biosynthesis of plasmalogens is not well understood. Further research is needed to fully understand the role of plasmalogens in health and disease, and to develop effective strategies for restoring plasmalogen levels in individuals with plasmalogen deficiency. Understanding Plasmalogens: Key Components of Cell Membranes Plasmalogens are a type of phospholipid found in cell membranes, playing crucial roles in maintaining cellular function and protecting against oxidative stress. Despite their importance, the biosynthesis of plasmalogens is not well understood and further research is needed to fully comprehend their role in health and disease. What are Plasmalogens? Plasmalogens are unique phospholipids found